Essex Investment Management CO LLC Revance Therapeutics, Inc. Transaction History

Essex Investment Management CO LLC

$536 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$4.65 - $9.31 $454,495 - $909,968	97,741 Added 79.84%	220,160 $1.08 Million
Q4 2023 Feb 07, 2024	BUY	$5.81 - $11.2 $224,678 - $433,115	38,671 Added 46.18%	122,419 $1.08 Million
Q3 2023 Nov 09, 2023	SELL	$11.47 - $25.07 $288,034 - $629,557	-25,112 Reduced 23.07%	83,748 $960,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $6,100 - $9,289	247 Added 0.23%	108,860 $2.76 Million
Q1 2023 May 04, 2023	BUY	$18.36 - $35.27 $746,884 - $1.43 Million	40,680 Added 59.88%	108,613 $3.5 Million
Q4 2022 Feb 02, 2023	SELL	$18.32 - $30.66 $12,622 - $21,124	-689 Reduced 1.0%	67,933 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $72,137 - $143,317	5,034 Added 7.92%	68,622 $1.85 Million
Q2 2022 Aug 12, 2022	SELL	$11.52 - $20.4 $10,609 - $18,788	-921 Reduced 1.43%	63,588 $879,000
Q1 2022 May 09, 2022	SELL	$12.36 - $20.31 $801,855 - $1.32 Million	-64,875 Reduced 50.14%	64,509 $1.26 Million
Q4 2021 Feb 10, 2022	SELL	$12.46 - $27.87 $24,184 - $54,095	-1,941 Reduced 1.48%	129,384 $2.11 Million
Q2 2021 Aug 12, 2021	SELL	$26.8 - $31.84 $205,395 - $244,021	-7,664 Reduced 5.51%	131,325 $3.89 Million
Q1 2021 May 12, 2021	BUY	$24.03 - $29.97 $1.5 Million - $1.87 Million	62,318 Added 81.28%	138,989 $3.89 Million
Q4 2020 Feb 12, 2021	SELL	$23.41 - $28.34 $546,131 - $661,143	-23,329 Reduced 23.33%	76,671 $2.17 Million
Q3 2020 Nov 12, 2020	BUY	$23.23 - $34.3 $764,220 - $1.13 Million	32,898 Added 49.03%	100,000 $2.51 Million
Q2 2020 Aug 04, 2020	SELL	$12.6 - $26.55 $414,514 - $873,441	-32,898 Reduced 32.9%	67,102 $1.64 Million
Q1 2020 May 04, 2020	BUY	$12.46 - $27.81 $1.25 Million - $2.78 Million	100,000 New	100,000 $1.48 Million
Q4 2018 Feb 06, 2019	SELL	$18.06 - $24.96 $1.58 Million - $2.18 Million	-87,355 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$27.45 - $33.35 $658,937 - $800,566	-24,005 Reduced 21.56%	87,355 $2.4 Million
Q1 2018 Apr 26, 2018	SELL	$29.15 - $37.4 $221,306 - $283,940	-7,592 Reduced 6.38%	111,360 $3.43 Million
Q4 2017 Feb 05, 2018	BUY	$24.55 - $36.3 $344,289 - $509,071	14,024 Added 13.37%	118,952 $4.25 Million
Q3 2017 Oct 30, 2017	BUY	$22.55 - $28.1 $2.37 Million - $2.95 Million	104,928	104,928 $2.89 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account